FIELD: chemistry.
SUBSTANCE: invention relates to biochemistry, particularly to an antigenic composition which is capable of stimulating a specific immune response against mycobacteria, comprising: the first mycobacterial antigenic polypeptide and the second mycobacterial antigenic polypeptide, as well as a method for production thereof. Also disclosed is the use of the first mycobacterial antigen and the second mycobacterial antigen to obtain a medicinal agent for stimulating a specific immune response against mycobacteria in a subject. The invention also relates to a method of diagnosing a mycobacterial infection using the said composition or using the first mycobacterial antigen and the second mycobacterial antigen.
EFFECT: invention provides the effective treatment or prevention of a mycobacterial infection.
25 cl, 7 dwg, 4 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MYCOBACTERIAL ANTIGEN COMPOSITION | 2015 |
|
RU2702194C2 |
| IMMUNOCONJUGATES OF DIRECTIVE EFFECT | 2010 |
|
RU2583876C2 |
| EXPRESSION OF NEW CELL MARKS | 2018 |
|
RU2796334C2 |
| CLOSTRIDIAL TOXIN NetB | 2008 |
|
RU2474587C2 |
| INFLUENZA HAEMAGGLUTININ AND NEURAMINIDASE VARIANTS | 2010 |
|
RU2535970C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTITUMOUR EFFECT, AND METHOD FOR REDUCING PD-L1 INHIBITING EFFECT ON HUMAN T-CELLS | 2016 |
|
RU2688692C2 |
| HYBRIDISATION OF HETEROOLIGOMER MYCOBACTERIAL ANTIGENS | 2015 |
|
RU2695462C2 |
| IMPROVED NOGO-A-BINDING MOLECULES AND PHARMACEUTICAL APPLICATION THEREOF | 2008 |
|
RU2513697C2 |
| ANTI-CD40-ANTIBODIES AND METHODS OF APPLICATION | 2012 |
|
RU2609647C2 |
| COMPOSITIONS AND METHODS FOR TREATING ACTIVE MYCOBACTERIUM TUBERCULOSIS INFECTION | 2013 |
|
RU2659149C2 |
